Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival
Lise Mette Rahbek Gjerdrum, Anders Woetmann, Niels Ødum, et al.
Leukemia (2007) Vol. 21, Iss. 12, pp. 2512-2518
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Cancer Cell (2015) Vol. 28, Iss. 6, pp. 690-714
Open Access | Times Cited: 1351
Regulatory T Cells in Cancer
Dimitrios Mougiakakos, Aniruddha Choudhury, Álvaro Lladser, et al.
Advances in cancer research (2010), pp. 57-117
Closed Access | Times Cited: 383
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 205.e1-205.e16
Closed Access | Times Cited: 353
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ulrik Ralfkiær, Peter Hagedorn, Nannie Bangsgaard, et al.
Blood (2011) Vol. 118, Iss. 22, pp. 5891-5900
Open Access | Times Cited: 231
A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix
Walayat Shah, Xiaofei Yan, Jing Li, et al.
Cellular and Molecular Immunology (2010) Vol. 8, Iss. 1, pp. 59-66
Open Access | Times Cited: 239
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox, Andrew L. Feldman, David A. Wada, et al.
Blood (2009) Vol. 114, Iss. 10, pp. 2149-2158
Open Access | Times Cited: 209
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
Marie K. Brimnes, Annette Juul Vangsted, Lene Meldgaard Knudsen, et al.
Scandinavian Journal of Immunology (2010) Vol. 72, Iss. 6, pp. 540-547
Closed Access | Times Cited: 208
Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway
Rasha Abu Eid, Raed Samara, Laurent Ozbun, et al.
Cancer Immunology Research (2014) Vol. 2, Iss. 11, pp. 1080-1089
Open Access | Times Cited: 140
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Yi-Lan Zhang, Jiang Li, Hao-Yuan Mo, et al.
Molecular Cancer (2010) Vol. 9, Iss. 1
Open Access | Times Cited: 137
CD4+CD25+FoxP3+ regulatory T cells are increased whilst CD3+CD4−CD8−αβTCR+ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden
Sylvia Feyler, M von Lilienfeld-Toal, Sarah Jarmin, et al.
British Journal of Haematology (2009) Vol. 144, Iss. 5, pp. 686-695
Open Access | Times Cited: 136
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
Katharina Kopp, Ulrik Ralfkiær, Lise Mette Rahbek Gjerdrum, et al.
Cell Cycle (2013) Vol. 12, Iss. 12, pp. 1939-1947
Open Access | Times Cited: 136
Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
Stéphanie Zdanov, Magis Mandapathil, Rasha Abu Eid, et al.
Cancer Immunology Research (2016) Vol. 4, Iss. 4, pp. 354-365
Open Access | Times Cited: 130
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 323-342
Closed Access | Times Cited: 105
Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression
Nicholas Borcherding, Andrew P. Voigt, Vincent Liu, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 10, pp. 2996-3005
Open Access | Times Cited: 104
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
Thorbjørn Krejsgaard, Niels Ødum, Carsten Geisler, et al.
Leukemia (2011) Vol. 26, Iss. 3, pp. 424-432
Closed Access | Times Cited: 107
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
Thorbjørn Krejsgaard, Ulrik Ralfkiær, Erik Clasen‐Linde, et al.
Journal of Investigative Dermatology (2011) Vol. 131, Iss. 6, pp. 1331-1338
Open Access | Times Cited: 104
IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma
Tomomitsu Miyagaki, Makoto Sugaya, Hiraku Suga, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 24, pp. 7529-7538
Closed Access | Times Cited: 102
Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes
Kevin M. Friedman, Peter A. Prieto, Laura Devillier, et al.
Journal of Immunotherapy (2012) Vol. 35, Iss. 5, pp. 400-408
Open Access | Times Cited: 99
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Toxins (2013) Vol. 5, Iss. 8, pp. 1402-1421
Open Access | Times Cited: 84
Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome
Christiane Querfeld, Steven T. Rosen, Joan Guitart, et al.
Blood (2013) Vol. 123, Iss. 8, pp. 1159-1166
Open Access | Times Cited: 84
The Four types of Tregs in malignant lymphomas
Jing Wang, Xiaoyan Ke
Journal of Hematology & Oncology (2011) Vol. 4, Iss. 1
Open Access | Times Cited: 82
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
Jan P. Nicolay, Jana D. Albrecht, Silvia Alberti Violetti, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1660-1671
Open Access | Times Cited: 42
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome
Thorbjørn Krejsgaard, Lise Mette Rahbek Gjerdrum, Elisabeth Ralfkiær, et al.
Leukemia (2008) Vol. 22, Iss. 12, pp. 2230-2239
Closed Access | Times Cited: 85
Tumor-specific regulatory T cells in cancer patients
Sytse J. Piersma, Marij J.P. Welters, Sjoerd H. van der Burg
Human Immunology (2008) Vol. 69, Iss. 4-5, pp. 241-249
Closed Access | Times Cited: 80
Page 1 - Next Page

Scroll to top